Multicenter Randomized-Controlled Trial for Ganjie Bingmei Tablet（甘桔冰梅） in Treating Acute Pharyngitis with Wind Heat Invading Lung Syndrome

SUN Mingjuan; HUANG Chunjiang; LI Yunying; QIAO Fengying; CHEN Xiaoning; LENG Hui

doi:10.13288/j.11-2166/r.2017.01.011

您当前的位置：

首页 >

文章列表页 >

Multicenter Randomized-Controlled Trial for Ganjie Bingmei Tablet（甘桔冰梅） in Treating Acute Pharyngitis with Wind Heat Invading Lung Syndrome

更新时间：2021-11-10

- Multicenter Randomized-Controlled Trial for Ganjie Bingmei Tablet（甘桔冰梅） in Treating Acute Pharyngitis with Wind Heat Invading Lung Syndrome
- Journal of Traditional Chinese Medicine Vol. 58, Issue 1, Pages: 38-41(2017)
- 作者机构：
  
  1. 云南省中医医院
  2. 广东省中医院
  3. 天津中医药大学第一附属医院
  4. 江苏省中医院
  5. 辽宁省中医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2017.01.011
  CLC： R276.1
- Published：2017
- 稿件说明：
移动端阅览
[1]孙铭涓,黄春江,李云英,谯凤英,陈小宁,冷辉.甘桔冰梅片治疗风热犯肺型急性咽炎多中心随机对照研究[J].中医杂志,2017,58(01):38-41.

SUN Mingjuan, HUANG Chunjiang, LI Yunying, et al. Multicenter Randomized-Controlled Trial for Ganjie Bingmei Tablet（甘桔冰梅） in Treating Acute Pharyngitis with Wind Heat Invading Lung Syndrome[J]. Journal of Traditional Chinese Medicine2017, 58(1): 38-41.
[1]孙铭涓,黄春江,李云英,谯凤英,陈小宁,冷辉.甘桔冰梅片治疗风热犯肺型急性咽炎多中心随机对照研究[J].中医杂志,2017,58(01):38-41. DOI： 10.13288/j.11-2166/r.2017.01.011.

SUN Mingjuan, HUANG Chunjiang, LI Yunying, et al. Multicenter Randomized-Controlled Trial for Ganjie Bingmei Tablet（甘桔冰梅） in Treating Acute Pharyngitis with Wind Heat Invading Lung Syndrome[J]. Journal of Traditional Chinese Medicine2017, 58(1): 38-41. DOI： 10.13288/j.11-2166/r.2017.01.011.

摘要

目的评价甘桔冰梅片治疗风热犯肺型急性咽炎的临床疗效和安全性。方法采用多中心、随机、双盲、安慰剂平行对照临床试验设计

共纳入240例患者

完成235例

其中治疗组119例、对照组116例。治疗组和对照组分别给予甘桔冰梅片和安慰剂治疗

均每次0.4 g

每日4次

疗程5天。疗程结束后观察两组疾病综合疗效及中医症状（包括咽痛、咽干灼热、咽黏膜充血、吞咽不利）疗效

观察并记录患者不良反应。结果治疗组临床痊愈率13.5%

总有效率87.4%

对照组临床痊愈率7.8%

总有效率54.3%

两组比较差异有统计学意义（P<0.05）

治疗组优于对照组。治疗组咽痛改善率为89.9%

对照组为61.2%;治疗组咽干灼热改善率为70.6%

对照组为52.6%;治疗组咽黏膜充血改善率为73.9%

对照组为48.3%;治疗组吞咽不利消失率为88.7%

对照组为76.6%

治疗组各症状改善率均优于对照组（P<0.05或P<0.01）。甘桔冰梅片未见明显毒副作用和不良反应。结论甘桔冰梅片治疗风热犯肺型急性咽炎疗效确切

安全性好。

Abstract

Objective To evaluate the clinical curative effect and safety of Ganjie Bingmei tablet（甘桔冰梅片）in treating acute pharyngitis with wind heat invading lung syndrome. Methods Using multi-center

randomized

double-blind

placebo parallel controlled clinical trial design

240 patients were included in which 235 cases completed

with 119 cases in the treatment group and 116 cases in the control group. The treatment group and the control group were treated by the Ganjie Bingmei tablet and placebo respectively

with 0. 4 g each time

4 times per day

totally for 5 days. Observed the comprehensive curative effect of the two groups and the curative effect of Chinese medicine symptoms（ including sore throat

dry pharynx and burning sensation

pharyngeal mucosal hyperemia

dysphagia）

and recorded the adverse reactions. Results In the treatment group

the clinical curative rate was13. 5%

and the total effective was 87. 4%; in the control group

the clinical curative rate was 7. 8%

and the total effective was 54. 3%. There were statistical differences in curative effect between the the two groups（ P < 0. 05）

and the curative effect in the treatment group was better than that in the control group. The improvement rate of pharyngalgia in the treatment group was 89. 9%

and that in the control group was 61. 2%. The improvement rate of dry pharynx and burning sensation in the treatment group was 88. 7%

and that in the control group was 52. 6%. The improvement rate of pharyngeal mucosal congestion in the treatment group was 73. 9%

and that in the control group was 48. 3%. The disappearance rate of dysphagia in the treatment group was 88. 7%

and that in the control group was 76. 6%

thus

the improvement rate of the symptoms were better than those in the control group（ P < 0. 05 or P < 0. 01）. Ganjie Bingmei tablet had no obvious toxic side effects and adverse reactions. Conclusion Ganjie Bingmei tablet in treating acute pharyngitis with wind heat invading lung syndrome seems to have definite curative effect

and the safety appears good.

关键词

Keywords

references

查看原文

Views

273

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Study on Chaiqin Xiaoyong Decoction （柴芩消痈饮） Combined with Jinhuang Ointment （金黄膏） for the Nodular Stage of Acne Mastitis of Liver Meridian Heat Accumulation Type：A Randomized，Double-Blind，Placebo-Controlled Trial

Clinical Effectiveness and Safety of Bairui Granules （百蕊颗粒） in Treating Patients with Acute Pharyngitis with Wind-Heat Syndrome： A Multi-Center， Double-Blind， Double-Simulation， Randomized Controlled Trial

Ganjiebingmei Tablet （甘桔冰梅片） in Treating Acute Pharyngitis with Wind-Heat Invading the Lung Syndrome： A Multicenter， Randomized， Double-blind Double-dummy Clinical Observation

Systematic Review on the Randomize-Controlled Trials of Perianal Eczema Treated by Chinese Medicine

Clinical Efficacy and Economic Evaluation of 1293 Non-Severe Adult Patients with Community-Acquired Pneumonia Treated by the Jiangsu Traditional Chinese Medicine Diagnosis and Treatment Protocol for Dominant Diseases：A Multicenter，Retrospective Real-World Cohort Study

Related Author

CHEN Hongfeng

CHENG Yiqin

YE Meina

HU Shengfang

SHEN Mengfei

KANG Yuanyuan

MA Feifei

MENG Tian

Related Institution

Ruijin Hospital， Shanghai Jiaotong University School of Medicine

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Dongzhimen Hospital，Beijing University of Chinese Medicine

The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine

The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰